Are you a 10/10? Tenecteplase in Ischemic Stroke

<p>Cassandra Schmitt, Pharm.D. (<a href='https://twitter.com/cjschmitt2'>@cjschmitt2</a>) describes the differences between thrombolytic agents used for the treatment of ischemic stroke, discusses the literature examining the efficacy and safety outcomes of tenecteplase, and identifies the role of tenecteplase in ischemic stroke thrombolysis.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>